WBR280: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) No edit summary |
Sergekorjian (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor=Gerald Chi | |QuestionAuthor=Gerald Chi (Reviewed by Serge Korjian) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|MainCategory=Microbiology, Pharmacology | |MainCategory=Microbiology, Pharmacology | ||
|SubCategory=Head and Neck, Musculoskeletal/Rheumatology | |SubCategory=Head and Neck, Hematology, Musculoskeletal/Rheumatology | ||
|Prompt=An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy? | |Prompt=An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy? | ||
|Explanation=Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies. | |Explanation=Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies. | ||
Line 30: | Line 30: | ||
|AnswerCExp=Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis | |AnswerCExp=Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis | ||
|AnswerD=Intravenous vancomycin | |AnswerD=Intravenous vancomycin | ||
|AnswerDExp=Intravenous vancomycin may be used as an alternative regimen for | |AnswerDExp=Intravenous vancomycin may be used as an alternative regimen for MRSA osteomyelitis | ||
|AnswerE=Intravenous cefazolin | |AnswerE=Intravenous cefazolin | ||
|AnswerEExp=Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis | |AnswerEExp=Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis | ||
|RightAnswer=A | |RightAnswer=A | ||
|WBRKeyword=Salmonella | |WBRKeyword=Salmonella, Osteomyelitis, Antibiotics, Thalassemia, Sickle cell disease | ||
|Approved=Yes | |Approved=Yes | ||
}} | }} |
Revision as of 15:27, 7 August 2015
Author | PageAuthor::Gerald Chi (Reviewed by Serge Korjian) |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Microbiology, MainCategory::Pharmacology |
Sub Category | SubCategory::Head and Neck, SubCategory::Hematology, SubCategory::Musculoskeletal/Rheumatology |
Prompt | [[Prompt::An 8-year-old girl with a history of thalassaemia major presents to the emergency department with low-grade fever, leg pain, and malaise for the past week. Her blood pressure is 110/60 mm Hg, heart rate is 90/min, and temperature is 37.8 ᵒC (100 ᵒF). On physical examination, her anterior left shin is red, swollen, and tender to palpation. Two sets of blood cultures are positive for gram-negative bacteria and MRI confirms a diagnosis of tibial osteomyelitis. Which of the following antimicrobial agent is the most appropriate initial therapy?]] |
Answer A | AnswerA::Intravenous ciprofloxacin |
Answer A Explanation | AnswerAExp::Intravenous ciprofloxacin is the drug of choice for Salmonella osteomyelitis |
Answer B | AnswerB::Intravenous linezolid |
Answer B Explanation | AnswerBExp::Intravenous linezolid may be used as an alternative regimen for MRSA osteomyelitis |
Answer C | AnswerC::Intravenous nafcillin |
Answer C Explanation | AnswerCExp::Intravenous nafcillin may be used as a primary regimen for S. aureus osteomyelitis |
Answer D | AnswerD::Intravenous vancomycin |
Answer D Explanation | AnswerDExp::Intravenous vancomycin may be used as an alternative regimen for MRSA osteomyelitis |
Answer E | AnswerE::Intravenous cefazolin |
Answer E Explanation | AnswerEExp::Intravenous cefazolin may be used as a primary regimen for S. aureus osteomyelitis |
Right Answer | RightAnswer::A |
Explanation | [[Explanation::Patients with a history of hemoglobinopathy such as sickle cell disease and thalassemia are prone to have osteomyelitis secondary to Salmonella infection. Other risk factors include transfusions and iron chelation therapies. Educational Objective: |
Approved | Approved::Yes |
Keyword | WBRKeyword::Salmonella, WBRKeyword::Osteomyelitis, WBRKeyword::Antibiotics, WBRKeyword::Thalassemia, WBRKeyword::Sickle cell disease |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |